-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NWj7CaHykInGev7rxhZomH867sue1Yr5pMMt5cZmJnB/Z0B5c89Dx2FSF9hNAkpn v/e/GMQACTttVRy7zOyAFQ== 0001123274-01-500011.txt : 20010815 0001123274-01-500011.hdr.sgml : 20010815 ACCESSION NUMBER: 0001123274-01-500011 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010814 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME TRANSGENICS CORP CENTRAL INDEX KEY: 0000904973 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043186494 STATE OF INCORPORATION: MA FISCAL YEAR END: 0103 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-46637 FILM NUMBER: 1708689 BUSINESS ADDRESS: STREET 1: 175 CROSSING BLVD CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 508620-970 MAIL ADDRESS: STREET 1: 175 CROSSING BLVD CITY: FRAMINGHAM STATE: MA ZIP: 01701 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BANQUE PICTET S A CENTRAL INDEX KEY: 0001123274 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1 BOULEVARD ROYAL STREET 2: LUXENBOURG CITY: LUXENBOURG L-2016 MAIL ADDRESS: STREET 1: 1 BOULEVARD ROYAL STREET 2: LUXENBOURG CITY: LUXENBOURG L-2016 STATE: A0 SC 13G 1 readmee.txt GENZYME TRANSGENICS CORP SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 GENZYME TRANSGENICS CORP ------------------------- (Name of Issuer) COMMON STOCK -------------------------------- (Title of Class of Securities) 37246E105 ---------------- (CUSIP Number) November 14th, 2000 --------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |X| Rule 13d-1(c) |_| Rule 13d-1(d) The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - - ------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Pictet Global Sector Fund - Biotech - - ------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |X| - - ------------------------------------------------------------------------- 3 SEC USE ONLY - - ------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Luxembourg - - ------------------------------------------------------------------------- 5 SOLE VOTING POWER 2'111'340 --------------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES BENEFICIALLY OWNED BY --------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON WITH --------------------------------------------------------- 8 SHARED DISPOSITIVE POWER - - ------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2'111'340 - - ------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |_| - - ------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.16% - - ------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* INVESTMENT FUND - - ------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT Item 1. (a) Name of Issuer: GENZYME TRANSGENICS (b) Address of Issuer's Principal Executive Offices: 175 Crossing Boulevard Framingham, MA 01702 United States Item 2. (a) Name of Person Filing: Pictet Global Sector Fund - Biotech (b) Address of Principal Business Office or, if none, Residence: Luxembourg (c) Citizenship: Luxembourg (d) Title of Class Securities: Common Stock (e) CUSIP Number: 37246E105 Item 3. Not applicable. Item 4. Ownership (a) Amount Beneficially Owned: 2'111'340 (b) Percent of Class: 7.16%. (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: (ii) shared power to vote or to direct the vote: (iii) sole power to dispose or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Item 5. Ownership of Five Percent or Less of a Class Not applicable. Item 6. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not Applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of the Group Not applicable. Item 10. Certification By signing below I certify that, to the best if my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquire and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: April 4th, 2001 Patrick Schott Jerry Hilger -------------- -------------- -------------- ------------- -----END PRIVACY-ENHANCED MESSAGE-----